Venetoclax as Consolidation in CLL Patients Treated With BTK Inhibitor Monotherapy
Clinical trial NCT06958705 · RECRUITING
Trial details
- NCT number
- NCT06958705
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-01
- Primary completion
- 2027-12-01
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.